Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQJDX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,245
Award facts
- Contract value 100% obligated
- $18,245.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors valued at $18,245.20. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Dupixent is a biologic immunosuppressant used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, representing the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers to support Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQJDX?
SPE2DB25FQJDX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FQJDX worth?
The government has obligated $18,245 on SPE2DB25FQJDX.
Is contract SPE2DB25FQJDX an order under another contract?
Yes. SPE2DB25FQJDX is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJDX competed?
The extent of competition for SPE2DB25FQJDX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award